4
Changes in Ownership
PLIANT THERAPEUTICS, INC. Filed Acc 0001746473-25-000015
Chief Business Officer acquired 40,150 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hull Hans Chief Business Officer | 2025-01-23 | Grant or award | +40,150 | 251,708 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hull Hans Chief Business Officer | 2025-01-23 | Grant or award · Stock Option (Right to Buy) | +80,300 | 80,300 | D: show line 2 in the form |
Loading xslF345X05/wk-form4_1738019230.xml…